These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22801574)

  • 1. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
    Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
    Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serpinb9 is a marker of antigen cross-presenting dendritic cells.
    Mangan MS; Vega-Ramos J; Joeckel LT; Mitchell AJ; Rizzitelli A; Roediger B; Kaiserman D; Weninger WW; Villadangos JA; Bird PI
    Mol Immunol; 2017 Feb; 82():50-56. PubMed ID: 28024184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage.
    Ansari AW; Temblay JN; Alyahya SH; Ashton-Rickardt PG
    J Immunol; 2010 Jul; 185(2):877-83. PubMed ID: 20543105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.
    Azzi J; Skartsis N; Mounayar M; Magee CN; Batal I; Ting C; Moore R; Riella LV; Ohori S; Abdoli R; Smith B; Fiorina P; Heathcote D; Bakhos T; Ashton-Rickardt PG; Abdi R
    J Immunol; 2013 Sep; 191(5):2319-27. PubMed ID: 23913965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death.
    Lovo E; Zhang M; Wang L; Ashton-Rickardt PG
    J Immunol; 2012 Feb; 188(3):1057-63. PubMed ID: 22227570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.
    Mangan MS; Bird CH; Kaiserman D; Matthews AY; Hitchen C; Steer DL; Thompson PE; Bird PI
    J Biol Chem; 2016 Feb; 291(7):3626-38. PubMed ID: 26670609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8α
    Parekh VV; Pabbisetty SK; Wu L; Sebzda E; Martinez J; Zhang J; Van Kaer L
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6371-E6380. PubMed ID: 28716903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules.
    Zhang M; Park SM; Wang Y; Shah R; Liu N; Murmann AE; Wang CR; Peter ME; Ashton-Rickardt PG
    Immunity; 2006 Apr; 24(4):451-61. PubMed ID: 16618603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
    Keech CL; Pang KC; McCluskey J; Chen W
    Eur J Immunol; 2010 Feb; 40(2):330-8. PubMed ID: 19950171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
    Stober D; Trobonjaca Z; Reimann J; Schirmbeck R
    Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.
    Jirmo AC; Nagel CH; Bohnen C; Sodeik B; Behrens GM
    J Immunol; 2009 Jan; 182(1):283-92. PubMed ID: 19109159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum.
    Lin JS; Yang CW; Wang DW; Wu-Hsieh BA
    J Immunol; 2005 May; 174(10):6282-91. PubMed ID: 15879127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
    Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
    Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.
    Schnorrer P; Behrens GM; Wilson NS; Pooley JL; Smith CM; El-Sukkari D; Davey G; Kupresanin F; Li M; Maraskovsky E; Belz GT; Carbone FR; Shortman K; Heath WR; Villadangos JA
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10729-34. PubMed ID: 16807294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
    Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K
    Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.